Trials / Terminated
TerminatedNCT01496235
Effect of Cocoa Consumption in Cardiovascular and Immune Parameters
Randomized Clinical Trial of the Effect of Cocoa Consumption in Cardiovascular and Immune Parameters in Colombian Patients With Newly Diagnosed Stage 1 Arterial Hypertension
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Universidad de Antioquia · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Arterial hypertension is one of the most preventable risk factors for stroke, cardiovascular and renal disease. Cocoa is rich in a subclass of flavonoid called flavanol this increase nitric oxide production and is involved in controlling blood pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Dark chocolate | Each chocolate bar provided 210 calories represented in 25 grams of carbohydrates, 3 g of proteins, 18 g of total fat and the presence of 70% cocoa solids |
| DIETARY_SUPPLEMENT | White chocolate | Each chocolate bar provided 230 calories represented in 28 grams of carbohydrates, 3 g of proteins, 18 g of total fat, without the presence of 70% cocoa solids |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2011-12-21
- Last updated
- 2011-12-21
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT01496235. Inclusion in this directory is not an endorsement.